Evidence map›Paper›PMID 35891290›Full record

ArticleVaccines2022

Motivators and Barriers to HPV Vaccination: A Qualitative Study of Underserved Women Attending Planned Parenthood.

Emilia J Fields, Suellen Hopfer, Jennifer R Warren, Rhonda BeLue, Joel Lebed, Michael L Hecht

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Motivated by mortality:Exploratory research in clinical and social pharmacy · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Beyond health: exploring women's socio-cultural motivations for HPV vaccination.International journal of qualitative studies on health and well-being · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Emilia J FieldsDepartment of Health, Society, and Behavior, Program in Public Health, University of California-Irvine, Irvine, CA 92697, USA.
Suellen HopferDepartment of Health, Society, and Behavior, Program in Public Health, University of California-Irvine, Irvine, CA 92697, USA.
Jennifer R WarrenDepartment of Communication, Women and Gender Studies, African and African American Studies, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-3325-1557
Rhonda BeLueDepartment of Public Health, University of Texas San Antonio, San Antonio, TX 78249, USA.
Joel LebedPlanned Parenthood Southeastern Pennsylvania, Philadelphia, PA 19107, USA.
Michael L HechtREAL Prevention, LLC, Clifton, NJ 07013, USA.
University of California, Irvine · USGeorge Mason University · USPlanned Parenthood · USReal Prevention (United States) · USThe University of Texas at San Antonio · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Feasibility of a Smartphone Kiosk intervention to increase HPV vaccinationR43CA192437 · NCI · REAL PREVENTION, LLC · PI HOPFER, SUELLEN · 2015 to 2015
$223k
NCATS NIH HHS UL1 TR001414NCI NIH HHS R43 CA192437
6 · The paper itself

Abstract

Human papilloma virus (HPV) is the most common sexually transmitted infection in the United States. Disease-associated strains of HPV can cause genital warts and six cancer types. HPV-associated cervical cancer disproportionately impacts medically underserved women including Black and Latina women with respect to incidence, prevalence, and mortality rates. Although safe and effective vaccines are available, HPV vaccination rates remain low among low-income individuals and women of color. The current study examined individual and structural motivators and barriers to HPV vaccination among medically underserved women utilizing a Planned Parenthood health center in Southeast Pennsylvania. Guided by narrative engagement theory (NET), qualitative interviews (N = 24) were used to elicit HPV vaccine decision stories from both vaccinated and unvaccinated women. Using a phronetic iterative data analysis approach, we identified three motivators to vaccinate against HPV: (1) receiving an explicit vaccine recommendation from a healthcare provider (a structural determinant), (2) feeling empowered to take control of one's health (an individual determinant), and (3) knowing someone infected with HPV (an individual determinant). Among unvaccinated participants, barriers to HPV vaccination included: (1) not receiving an explicit vaccine recommendation from a healthcare provider (a structural determinant), (2) low perceived risk for acquiring HPV or that HPV is not severe (an individual determinant), and (3) lack of maternal support to vaccinate (a structural determinant). Healthcare providers are optimally positioned to fill the gap in prior missed vaccine opportunities and empower women by recommending HPV vaccination.

Indexed as

Black womenfederally qualified health centers (FQHC)HPV vaccineLatina womenPlanned Parenthood

Identifiers

PMID35891290
PMCPMC9317585
OpenAlexW4285733673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.